OncoMed Pharmaceuticals Inc. said Sunil Patel plans to resign as CFO effective on or about March 9.
Patel notified the California-based biotech company Jan. 28, OncoMed said in an SEC filing.
OncoMed Pharmaceuticals CFO resigns
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
OncoMed Pharmaceuticals Inc. said Sunil Patel plans to resign as CFO effective on or about March 9.
Patel notified the California-based biotech company Jan. 28, OncoMed said in an SEC filing.